Trans Fat Footnote Statement On Food, Supplement Labeling Proposed By FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeking comments on the proposed use of a footnote statement on food and dietary supplement products containing trans fat that would advise consumers against excessive intake of the ingredient
You may also be interested in...
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Manufacturers of dietary supplements that contain more than .5 g of trans fat will be required to list the amount of the ingredient, as well as the amounts of saturated fat and cholesterol, on the Supplement Facts panel by Jan. 1, 2006
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Manufacturers of dietary supplements that contain more than .5 g of trans fat will be required to list the amount of the ingredient, as well as the amounts of saturated fat and cholesterol, on the Supplement Facts panel by Jan. 1, 2006
Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule
Manufacturers of dietary supplements that contain more than .5 g of trans fat will be required to list the amount of the ingredient, as well as the amounts of saturated fat and cholesterol, on the Supplement Facts panel by Jan. 1, 2006